Recruitment and reach in a pragmatic behavioral weight loss randomized controlled trial: implications for real-world

Christie A Befort1, Danny Kurz2, Jeffrey J VanWormer3

  • 1Department of Population Health, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1008, Kansas City, KS, 66160, USA. cbefort@kumc.edu.

BMC Family Practice
|March 5, 2020
PubMed
Abstract

Insights

Effective obesity treatment reach in primary care can be improved through combined patient mailings and clinic referrals. Further strategies are needed to engage men, younger patients, and those at greater medical risk.

Area of Science:

  • Obesity research
  • Primary care interventions
  • Health services research

Background:

  • Obesity is a significant risk factor for common primary care conditions.
  • Effective obesity treatments exist but have poor reach, with few patients receiving evidence-based care.
  • Limited intervention uptake in primary care settings necessitates understanding reach determinants.

Purpose of the Study:

  • To identify factors influencing the uptake (reach) of an evidence-based obesity treatment program.
  • To evaluate reach within a pragmatic cluster randomized controlled trial comparing three care delivery models.

Main Methods:

  • Recruitment and reach assessed via mailing response rates, referral sources, eligibility, and participation rates.
  • Compared 1432 enrolled participants against >17,000 non-participants on demographics and healthcare utilization.
  • Analyzed referral sources and participation rates across study arms and clinic engagement levels.

Main Results:

  • Clinic mailings yielded a 13.2% response rate, contributing 66% to recruitment; direct clinic referrals added 22%.
  • Eligibility and enrollment rates were high (87% and 86%, respectively).
  • Participation was similar across care models but higher in clinics with greater provider involvement, which also showed more representative recruitment.

Conclusions:

  • Combining direct patient mailings and in-clinic referrals can enhance reach for primary care weight loss interventions.
  • Proactive outreach is crucial for engaging men, younger patients, and those with higher medical risk.
  • Strategies to boost provider engagement in patient referrals to weight loss programs are essential.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
340
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
190
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
166
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
377
Stress Prevention and Stress Management Techniques VI01:30

Stress Prevention and Stress Management Techniques VI

Adopting a healthier lifestyle often requires overcoming significant challenges, but leveraging psychological, social, and cultural resources can facilitate meaningful change. Effective self-change hinges on understanding and applying key tools such as motivation and goal setting, which help sustain efforts toward long-term health benefits.
Motivation and Self-Determination
Motivation, the driving force behind behavior, plays a pivotal role at every stage of the change process. The research...
191